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Introduction 
Throughout evolutionary history, the process of natural selection has resulted in a remarkable 
diversity of defensive adaptations that help organisms deter or avoid predation.  One such 
adaptation is chemical defenses.  Organisms that use chemical defenses possess unpalatable or 
toxic compounds that discourage attack from potential predators.  While most species synthesize 
their own chemical defenses, some sequester compounds from their diet (Saporito et al. 2012; 
Savitzky et al. 2012).  For instance, certain organisms acquire toxins from their food and store 
them within their tissues, typically in specialized structures such as glands or spines (Saporito et 
al. 2012; Savitzky et al. 2012).  A variety of organisms have the ability to sequester chemical 
defenses, including arthropods, snakes, and birds, but this mechanism has been best studied in 
amphibians, specifically poison frogs (Daly et al. 1994; Saporito et al. 2012; Savitzky et al. 
2012). 
 Poison frogs in the families Dendrobatidae, Bufonidae, Mantellidae, Myobatrachidae, 
and Eleutherodactylidae sequester lipophilic alkaloids from a diet of arthropods such as mites, 
ants, beetles, and millipedes (for review, see Saporito et al. 2009).  Many types of alkaloids have 
been identified in poison frog species, which include over 850 unique alkaloid compounds 
categorized into more than 20 structural classes.  In general, arthropods possess different types 
and classes of alkaloids, so the specific set of alkaloids sequestered by an individual frog varies 
based on the arthropods in each frog’s diet.  As such, there is significant variation in the types 
and quantities of alkaloids between individual frogs based on their sex, age, and other 
characteristics (Saporito et al. 2009, 2012).  Furthermore, alkaloid composition varies among 
populations of frogs, and several studies have shown that frog populations from geographically 
close locations have similar alkaloid profiles while more distant populations have greater 
differences in alkaloid composition (Daly et. al 1994; Saporito et al. 2007; Saporito et al. 2012; 
Stuckert et al. 2014; Mina et al. 2015). 
 In addition to serving as a chemical defense from predators, recent research has shown 
that alkaloids may defend poison frogs against infection from microorganisms (MacFoy et al. 
2005; Mina et al. 2015).  Frogs have moist skin and often live in environments that are ideal for 
the growth of potentially pathogenic microbes, such as decaying leaf-litter, rotting logs, or slow 
moving-bodies of water (Pough et al. 2003).  These conditions would presumably make frogs 
highly susceptible to infection; however, frogs appear to have some defenses that are effective 
3 
 
against microbes (Daly et al. 1987; Clarke 1996).  Frog skin secretions contain a wide variety of 
biologically active chemicals, including proteins, peptides, steroids, and alkaloids (Daly et al. 
1987; Daly et al. 2005; Macfoy et al. 2005).  Some of these – especially peptides, which are 
manufactured de novo by various frog species – have been found to possess significant 
antimicrobial properties (Bevins and Zasloff 1990; Clarke 1996; Rinaldi 2002). 
 More recently, researchers have determined that individual alkaloids such as 
pumiliotoxins and indolizidines found in dendrobatids and other poison frogs are effective 
antimicrobial agents against the bacteria Bacillus subtilis and Escherischia coli as well as the 
fungus Candida albicans (Macfoy et al. 2005).  During the last few years, researchers have 
begun to examine the antimicrobial effects of alkaloid cocktails, using the entire complement of 
alkaloids extracted from a frog, rather purified individual alkaloids.  Alkaloid cocktails from 
geographically isolated populations of the dendrobatid frog Oophaga pumilio and the bufonid 
toad Melanophryniscus simplex were found to inhibit the growth of B. subtilius, E. coli, and C. 
albicans to varying degrees (Gronemeyer 2013; Mina et al. 2015).  Gronemeyer (2013) reported 
that the alkaloid cocktails in M. simplex, which had greater alkaloid diversity (i.e., more types of 
alkaloids) than that of O. pumilio were more effective at inhibiting microbial growth.  This may 
indicate that alkaloids have a synergistic effect; that is, greater alkaloid diversity results in 
greater microbial growth inhibition (Gronemeyer 2013).  Mina et al. (2015) tested alkaloids from 
five populations of O. pumilio against the same microbes and found that each population 
inhibited growth of E. coli and B. subtilis, while only one population inhibited the growth of C. 
albicans.  This suggests that there are differences in inhibition among frog populations and 
between microbe species. 
 Melanophryniscus simplex, commonly known as the red-belly toad, is a Brazilian poison 
frog.  Recent research has shown that the red-belly toad possesses alkaloids not only in its skin, 
but also in muscle, liver, and mature oocytes (Grant et al. 2012).  This discovery supports the 
hypothesis that alkaloids play a role in “help[ing] prevent or suppress infection by non-skin 
penetrating parasites” (Grant et al. 2012).  Sixteen different classes of alkaloids have been 
detected in M. simplex skins, and each individual frog has an average of 38 unique alkaloid 
compounds (Daly et al. 2007; Daly et al. 2008; Grant et al. 2012).  This represents a relatively 
diverse alkaloid cocktail, which may result in greater antimicrobial effects.  The goals of the 
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present study were to test the effectiveness of alkaloid cocktails from six geographically isolated 
populations of M. simplex against two bacteria in the genus Mycobacterium. 
 The genus Mycobacterium is comprised of over 150 species of Gram-positive bacteria, 
most of which are harmless and commonly found in the environment (Balazova et al. 2014).  
However, some species of Mycobacterium are pathogenic in humans and other animals.  For 
example, M. tuberculosis and M. leprae cause tuberculosis and leprosy (respectively) in humans.  
Additionally, M. bovis and M. avium cause disease in cattle and other mammals (Rue-Albrecht et 
al. 2014).  Several species have also been known to cause infection in frogs, including M. 
marinum, M. ulcerans, and M. lifelandii (Haridy et al. 2014; Tobias et al. 2013; Suykerbuyk et 
al. 2007).  Several previous studies support the idea that some alkaloids from other sources – 
plants, sponges, and tunicates – are effective antimycobacterial agents (Houghton et al. 1998; 
Arai et al. 2014; Sureram et al. 2012; Appleton et al. 2010); however, it is not known if alkaloids 
from frog skins could provide protection against mycobacteria. 
 This study investigated the antimycobacterial properties of M. simplex alkaloids from 
geographically isolated populations against two species of mycobacteria, M. smegmatis, a soil-
dwelling species, and M. phlei, a saprophytic species (Berney et al. 2014; Egamberdieva 2011).  
Both of these species are fast-growing, commonly found in the environment, and typically 
nonpathogenic in healthy animals (Balazova et al. 2014, Berney et al. 2014, Egamberdieva 
2011).  Both M. smegmatis and M. phlei are commonly used as model strains for the study of 
antimycobacterial agents (Zhang et al. 2014, Bruce-Micah et al. 2009).  Optical density and 
colony-forming unit assays were used to evaluate the antimycobacterial effect of these alkaloids.  
Optical density was used as a measure of growth inhibition, i.e. the alkaloids’ ability to prevent 
the bacteria from growing.  Colony-forming unit assays were used to measure the decrease in 
viability of the bacteria, i.e. the alkaloids’ ability to kill the bacteria.  Ultimately, this study will 
provide useful information regarding the role alkaloids play in the microbial defense of poison 
frogs, especially against mycobacterial pathogens in M. simplex. 
 
Methods 
Frog samples.  In this study, alkaloids were extracted from M. simplex skins preserved in 
methanol.  Alkaloid cocktails were isolated from 18 individual frogs from 6 geographically 
isolated Brazilian populations (Figure 1).  The frogs used in the present study were a part of a 
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larger study aimed at understanding the link between alkaloid variation and arthropod diet 
among populations of M. simplex (see Grant et al. 2012). Three frogs were randomly selected 
from each of the six populations, and represent a sub-sample of the original collection of M. 
simplex. 
 
Alkaloid fractionation.  The method of alkaloid fractionation was described in Saporito et al. 
2009 and Grant et al. 2012.  Each frog skin was preserved in 4 mL of methanol in a glass vial 
with a Teflon-lined ® cap (methanol-skin solution).  First, 1 mL of the methanol-skin solution 
was added to a conical glass vial with 50 µL of HCl.  After mixing, each sample was 
concentrated with nitrogen gas to a volume of 100 µL.  Next, 200 µL of water was added to the 
sample.  The sample was then extracted four times with 300 µL portions of hexane, and the 
hexane layer was removed.  The resulting solution was then basified with saturated NaHCO3 and 
tested with pH paper to confirm basicity.  Then, three extractions with 300 µL portions of ethyl 
acetate were carried out.  The ethyl acetate alkaloid layer was removed and dried with anhydrous 
Na2SO4.  The sample was then concentrated to dryness with nitrogen gas.  The remaining pure 
alkaloids were suspended 100 µL of methanol and stored at -15°C until use in optical density 
assays. 
 
Pilot studies.  To determine the optimal growth period for accurate evaluation of inhibition and 
lethality, pilot studies were completed for M. smegmatis and M. phlei.  Based on previous 
research using mycobacteria (Houghton et al. 1998; Arai et al. 2014; Sureram et al. 2012; 
Appleton et al. 2010) as well as optical density measurements of the growth of untreated M. 
smegmatis and M. phlei, a liquid culture of each bacterium was grown at 37°C with agitation in a 
7H9 nutrient broth.  The culture was filtered through a 0.5 µm filter. Optical density 
measurements of 200 µL samples of the broth were taken every 30 minutes at 620 nm with five 
seconds of agitation before each measurement.  Growth curves were plotted for each bacterium 
over various periods of time, and it was determined that a 48 hour optical density measurement 
period would best capture the lag, exponential, stationary, and decline phases of growth for both 
bacteria. 
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Optical density assay.  For both Mycobacterium smegmatis and Mycobacterium phlei, a liquid 
culture was grown for 48 hours in a 7H9 nutrient broth at 37°C with agitation.  Two hundred 
microliters of filtered culture were mixed with either 4.8 µL or 9.6 µL of fractionated alkaloid 
samples. These volumes were based upon the findings of Mina et al. (2015), in which 4.8 µL was 
shown to be effective against other bacteria as a minimal inhibitory dose.  To determine whether 
a dose-response relationship existed in comparison to the 4.8 µL treatments, replicates were 
treated with 9.6 µL of alkaloid as well.  Three replicates were completed for each individual at 
each volume.  Additionally, three replicates were treated with 4.8 µL and 9.6 µL of methanol 
alone to determine whether the methanol in which the alkaloids were suspended had an effect on 
the growth of the bacteria.  Using a 96-well plate spectrophotometer, optical density 
measurements were taken at 620 nm every 30 minutes over 48 hours at 37°C.  The plate was 
agitated for five seconds prior to each measurement.  Based on the normal growth curve of each 
bacteria, inhibition in optical density assays was evaluated at the endpoint of the measurements. 
 
Colony-forming unit (CFU) assay.  Once the optical density measurements were complete, 
dilutions of broth cultures from each treated well were spotted in 10 µL aliquots onto 7H11 agar 
plates.  The first column was a pure sample from the treated well.  From the pure sample, tenfold 
dilutions were performed in 7H9 nutrient broth and spotted onto the plates (Figure 2).  These 
cultures were grown at 37°C for 48 hours.  Following the growth period, the colonies were 
counted and the number of colony-forming units per milliliter of broth were determined using the 
following formula: 
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Statistical analyses.  Mean optical densities and mean colony-forming units were compared 
among populations and methanol controls with a one-way Analysis of Variance (ANOVA).  
Pair-wise comparisons were analyzed using Tukey post-hoc tests.  All statistical analyses were 
completed using GraphPad Prism 6. 
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Results 
Mycobacterium smegmatis.  Optical density assays of M. smegmatis treated with 4.8 µL of 
alkaloid (Figure 3A) demonstrated that alkaloids from Site 1 (p-value ≤ 0.001), Site 3 (p-value = 
0.002), and Site 6 (p-value = 0.050) inhibited the growth of the bacteria significantly more than 
the methanol control.  There were no significant differences in inhibition between the alkaloids 
from sites 1, 3, and 6 (p-value > 0.05 in all comparisons).  Colony-forming unit assays of M. 
smegmatis treated with 4.8 µL of alkaloid (Figure 3B) showed that alkaloids from Site 1 (p-value 
≤ 0.001), Site 2 (p-value ≤ 0.001), and Site 3 (p-value ≤ 0.001) were significantly more lethal to 
the bacteria than the methanol control.  There were no significant differences in lethality between 
populations 1, 3, and 6 (p-value > 0.05 in all comparisons). 
 According to optical density assays of M. smegmatis treated with 9.6 µL of alkaloid 
(Figure 3C), alkaloids from Site 2 (p-value = 0.014), Site 3 (p-value = 0.002), Site 4 (p-value ≤ 
0.001), Site 5 (p-value ≤ 0.001), and Site 6 (p-value ≤ 0.001) inhibited bacterial growth 
significantly more than the methanol control.  Between these populations, there were significant 
differences in inhibition between Sites 2 and 6 (p-value = 0.037), Sites 4 and 6 (p-value = 0.003), 
and Sites 5 and 6 (p-value = 0.004).  Colony-forming unit assays of M. smegmatis treated with 
9.6 µL of alkaloid indicated that alkaloids from Site 1 (p-value ≤ 0.001), Site 2 (p-value = 0.011), 
Site 3 (p-value ≤ 0.001), and Site 4 (p-value = 0.044) were significantly more lethal to the 
bacteria than the methanol control.  Among these populations, there were significant differences 
in inhibition between Sites 1 and 2 (p-value = 0.021), Sites 1 and 4 (p-value ≤ 0.001), Sites 2 and 
3 (p-value = 0.010), and Sites 3 and 4 (p-value ≤ 0.001). 
 
Mycobacterium phlei.  Optical density assays of M. phlei treated with 4.8 µL of alkaloid (Figure 
4A) showed that alkaloids from Site 1 and Site 3 inhibited the growth of the bacteria 
significantly more than the methanol control (p ≤ 0.001 in both cases).  There was no statistically 
significant difference between the inhibition caused by alkaloids from Site 1 and Site 3 (p-value 
= 0.910).  The samples treated with alkaloids from Site 5 grew significantly more than those 
treated with methanol (p-value ≤ 0.001).  However, colony-forming unit assays of M. phlei 
treated with 4.8 µL of alkaloid (Figure 4B) indicated no significant differences in lethality 
between any population and the methanol control (p-value > 0.05 in all comparisons). 
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For optical density assays of M. phlei treated with 9.6 µL of alkaloid (Figure 4C), 
samples treated alkaloids from Site 4 grew significantly more than the methanol control (p-value 
= 0.019).  Colony-forming unit assays of M. phlei treated with 9.6 µL of alkaloid (Figure 4D) 
indicated that alkaloids from Site 1 (p-value = 0.025) and Site 3 (p-value = 0.031) were 
significantly more lethal to the bacteria than the methanol control.  The mean colony-forming 
units per milliliter for Site 6 was much lower than that of methanol; however, this difference was 
not statistically significant (p-value = 0.093), likely because Site 6 had a relatively smaller 
sample size than the rest of the populations due to some of the assays being unreadable or too 
numerous to count.   There were no significant differences in lethality between Site 1 and Site 3 
(p-value = 0.133). 
 
Discussion 
This study investigated the hypothesis that alkaloid-based skin secretions protect the poison frog 
M. simplex from infection by bacteria in the genus Mycobacterium, some of which are known to 
be pathogenic in frogs.  Two methods, optical density assays and colony-forming unit assays, 
were used to measure the antimycobacterial properties of the alkaloids.  The data for M. 
smegmatis showed that alkaloids from several populations inhibited growth and were lethal to 
the bacteria at 4.8 µL.  Nearly all of the populations inhibited growth at 9.6 µL in both optical 
density and colony-forming unit assays, demonstrating a dose-response relationship.  Further, 
there were significant differences in inhibition among populations.  The data from M. phlei was 
inconsistent and inconclusive, and control trials suggested that the methanol in which the 
alkaloids were suspended had a significant effect on bacterial growth, which acted as a 
confounding factor.  The data from M. smegmatis lends further support to the hypothesis that 
certain alkaloid compounds inhibit microbial growth, with variation in inhibition based on 
geographic location. 
The first method of measuring microbial inhibition, optical density, indicated that 
alkaloids inhibit the growth of M. smegmatis.  This inhibition varies among populations and 
exhibits a dose-response relationship.  When M. smegmatis was treated with 4.8 µL of alkaloid, 
the optical density indicated that three populations (Sites 1, 3, and 6) inhibited microbial growth 
significantly more than the methanol control.  When the volume of alkaloid was increased to 9.6 
µL, five of the six populations inhibited bacterial growth significantly more than the methanol 
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control.  Though not statistically significant, there was some degree of inhibition in Site 1 
(though this specific test was likely confounded by an outlier frog with less alkaloid diversity 
and richness).
1
 The fact that more populations were inhibitory at 9.6 µL than at 4.8 µL suggests a 
dose-response relationship, which is consistent with microbial inhibition.  Further, there were 
significant differences in inhibition among several populations, supporting the idea that 
differences in alkaloid composition as a result of geographic isolation results in differential 
microbial inhibition. 
On the other hand, the optical density results for M. phlei were inconsistent, with 
alkaloids from some populations (Site 1 and Site 3) inhibiting growth at 4.8 µL, but without 
significant inhibition at 9.6 µL.  Further, cultures treated with alkaloids from two populations 
(Site 5 at 4.8 µL and Site 4 at 9.6 µL) grew significantly more than the methanol control.   
Clearly, there are some discrepancies in these results.  However, the growth curve of M. phlei 
treated with methanol alone suggests that the methanol in which the alkaloids were suspended 
had a significant effect on M. phlei, which was not seen in M. smegmatis.  As a result, it is 
impossible to determine the effect caused by the alkaloids alone based on this study.  For studies 
in which alkaloids are suspended in methanol, it is likely that M. phlei is not a good model for 
mycobacterial growth inhibition due to the methanol acting as a confounding factor.  Further 
research should fully investigate the effect of methanol on this particular bacterial species. 
The second method of analysis, colony-forming unit assays, also demonstrated inhibition 
of M. smegmatis, which was consistent with the optical density results for this microbe.  The 
alkaloids collected from Sites 1, 2, and 3 were lethal to M. smegmatis at 4.8 µL.  At this volume, 
only alkaloids from Sites 1 and 3 inhibited growth of the bacteria in the optical density assay, but 
                                                          
1
 Although the mean endpoint optical density was approximately equal to that of the other 
populations and lower than that of methanol (Figure 3C), the inhibition was not statistically 
significant when compared to the methanol control (p-value = 0.07).  However, the cultures 
treated with alkaloids from one particular frog from Site 1 had an unusually high optical density 
at both 4.8 µL and 9.6 µL.  Because there is variation in the alkaloids of individuals from the 
same population (Saporito et al. 2012), it is suspected that this individual had a less diverse 
alkaloid composition or lower quantities of alkaloids, which may have resulted in lower 
inhibition.  The presence of an outlier increases the standard error and reduces the ability to 
detect a statistical significant difference.  The fact that the alkaloids collected from Site 1 were 
inhibitory or lethal to M. smegmatis in all other analyses (optical density at 4.8 µL, colony-
forming units at 4.8 µL and 9.6 µL) supports the hypothesis that some frogs from Site 1 are, in 
fact, inhibitory, but as an entire site, are confounded by an outlier in this specific test. 
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the alkaloids from Site 2 did not.  However, this result is not unusual because optical density 
may “[measure] live as well as dead bacterial cell debris” (Pan et al. 2014); therefore, it is 
possible that a culture with a high optical density may have low viability as determined by the 
colony-forming unit assay.  At 9.6 µL, alkaloids from Sites 1, 2, 3, and 4 were found to be lethal 
to M. smegmatis, which is consistent with the optical density results that showed that alkaloids 
from all sites were inhibitory (although the inhibition of Site 1 was not statistically significant; 
see above for further discussion on Site 1).  These results also indicate that alkaloids from Sites 5 
and 6 inhibited the growth of the bacteria, but were not lethal to the bacteria (i.e., they did not 
reduce of the viability of the bacteria).  Moreover, at 9.6 µL, there were significant differences in 
lethality among populations, lending further support to the hypothesis that difference in alkaloid 
composition results in difference in microbial inhibition. 
In M. phlei, colony-forming unit assays showed that none of the alkaloids were 
significantly more lethal to the methanol at 4.8 µL, and only the alkaloids from Site 1 and Site 3 
were more lethal to the bacteria at 9.6 µL.  The lack of significant difference in inhibition 
between the methanol control and each population, as well as the lack of consistency with the 
optical density results for M. phlei, lend further support to the hypothesis that the methanol 
vehicle was a confounding factor for the results with this species of mycobacteria.  Thus, no 
meaningful conclusions can be drawn regarding the alkaloids’ ability to affect the growth or 
viability of M. phlei. 
The relationship between microbial inhibition and alkaloids cannot be fully described 
without an analysis of the specific alkaloid compounds that are most and least effective in terms 
of microbial growth inhibition and lethality.  Unfortunately, the alkaloids present in the frog 
skins of the present study have not yet been characterized. However, previous research has 
demonstrated that there are significant differences in alkaloid quantity and diversity between 
geographically isolated populations of M. simplex (Grant et al. 2012).  Grant et al. (2012) also 
reported that pumiliotoxins, 5,8-disubstituted indolizidines, 5,6,8-trisubstituted indolizidines, 
3,5-disubstituted pyrrolizidines, and some other izidines are well-distributed among M. simplex 
populations in the region represented by the present study.  Some of these alkaloid classes, such 
as pumiliotoxins and indolizidines, were shown by Macfoy et al. (2005) to inhibit the growth of 
Escherischia coli, Bacillus subtilis, and Candida albicans.  Based on the results of the present 
study, it is likely that the alkaloids collected from frogs in Site 1 and Site 3 have the strongest 
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antimicrobial effects because they were active against M. smegmatis in both assays even at a 
lower volume (4.8 µL), compared to Site 5, which showed no inhibitory activity at 4.8 µL.  A 
future study will need to characterize the specific alkaloid compounds present in the samples 
used in the present study to determine which alkaloids serve as the best defense against the 
mycobacterial species M. smegmatis. 
In conclusion, this is the first study to demonstrate that frog alkaloids from M. simplex 
effectively inhibit the growth of bacteria in a genus known to be pathogenic in anurans.  
Therefore, if M. smegmatis is a good model for other species of mycobacteria, it is possible that 
alkaloids defend this species of poison frog (and possibly others) from infection as well as 
predators.  As suggested by the variation in inhibition and lethality among populations, the level 
of defense from infection likely varies among populations, which is likely based on differences 
in the alkaloid profiles of geographically isolated locations.  Future research should investigate 
microbial growth inhibition and lethality in microbes that are known to be pathogenic to anurans 
and that are known to naturally occur in poison frog habitats. 
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Figure 1.  Map of Melanophryniscus simplex collection locations in Brazil.  Note: Sites 5 and 6 
are geographically close, but represent distinct collection locations.        
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Figure 2.  Colony-forming unit (CFU) assay for frog alkaloids tested against Mycobacterium 
phlei.  Rows 1-3 were treated with 4.8 microliters of alkaloid; rows 4-6 were treated with 9.6 
microliters of alkaloid.  Column A is a pure culture of M. phlei, followed by a tenfold dilution in 
each successive column. 
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Figure 3.  Optical density and colony-forming unit analyses for Mycobacterium smegmatis. 
(A) Mean endpoint optical density measurements for Mycobacterium smegmatis treated with 4.8 
microliters of alkaloid.  The dotted line represents the level of inhibition by the methanol control.  
(B) Mean colony-forming units per mL for Mycobacterium smegmatis treated with 4.8 
microliters of alkaloid.  (C) Mean endpoint optical density measurements for Mycobacterium 
smegmatis treated with 9.6 microliters of alkaloid.  The dotted line represents the level of 
inhibition by the methanol control. (D) Mean colony-forming units per mL for Mycobacterium 
smegmatis treated with 9.6 microliters of alkaloid. 
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Figure 4.  Optical density and colony-forming unit analyses for Mycobacterium phlei. (A) Mean 
endpoint optical density measurements for Mycobacterium phlei treated with 4.8 microliters of 
alkaloid.  The dotted line represents the level of inhibition by the methanol control. (B) Mean 
colony-forming units per mL for Mycobacterium phlei treated with 4.8 microliters of alkaloid. 
(C) Mean endpoint optical density measurements for Mycobacterium phlei treated with 9.6 
microliters of alkaloid.  The dotted line represents the level of inhibition by the methanol control. 
(D) Mean colony-forming units per mL for Mycobacterium phlei treated with 9.6 microliters of 
alkaloid. 
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